Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Cancer Survivors 1

Interventions

Cisplatin 20 Docetaxel 19 Capecitabine 19 Oxaliplatin 14 Drug Therapy 14 Cyclophosphamide 14 Paclitaxel 13 Fluorouracil 12 Radiotherapy 11 apatinib 9 Gemcitabine 9 Doxorubicin 9 Decitabine 9 Methotrexate 8 Epirubicin 8 Carboplatin 8 sintilimab 6 Etoposide 6 camrelizumab 5 anlotinib 5 XELOX 5 Sorafenib 5 Radiation 5 Pemetrexed 5 Neoadjuvant Therapy 5 Leucovorin 5 Idarubicin 5 Dexamethasone 5 Cytarabine 5 Busulfan 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Unknown × Employment, Supported × Clear all

NCT06028048 2023-09-29

PLACES

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 2/3 Unknown

Cancer Survivors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡